Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2028

Conditions

Soft Tissue Sarcoma (STS)

Interventions

BIOLOGICAL

umbilical cord blood NK cells

All subjects will receive Ex vivo Expanded and activated umbilical cord blood NK cells infusion.

Trial Locations (2)

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

RECRUITING

Dongguan Taixin Hospital, Dongguan

All Listed Sponsors

lead

Sun Yat-sen University

OTHER